Clinical efficacy of anlotinib plus S-1 as a second-line therapy for recurrent or metastatic esophageal squamous cell carcinoma
SUN Wei
ZOU Xi
ZHANG Wei
HU Shouyou
GE Kewei
Machine-generated Keywords：
Publication Date：2021-02-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 250-255 )